(Q45861548)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jacques Van Dongen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Y Y Ng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M R M Baert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

K Pike-Overzet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Rodijk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A Schambach

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

C Baum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

R W Hendriks

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

F J T Staal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

24 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1617-1630

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20574453%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2010.140

6 February 2020

exact match

0 references

cites work

Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

Human primary immunodeficiency diseases: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Gene therapy for severe combined immunodeficiency: are we there yet?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

The role of Tec family kinases in myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Defective B cell development and function in Btk-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Genetic analysis of patients with defects in early B-cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Potential application of gene therapy to X-linked agammaglobulinemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

HIV-1 integration in the human genome favors active genes and local hotspots

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for P

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

An antibody-deficiency syndrome due to mutations in the CD19 gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

WNT signalling in the immune system: WNT is spreading its wings

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

HIV-mediated expression of Btk in hematopoietic stem cells is not sufficient to restore B cell function in X-linked immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

Gene therapy of inherited diseases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021

B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.140

7 January 2021